ARTL

Artelo Biosciences Inc

8.93

+4.78+115.18%

Opening14:31 09/23 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.020/4.150

TODAY RANGE3.900-15.73

VOL19.28M

MARKET CAP4.89M

52 WEEK RANGE3.450-179.19

AVG VOL (3M)64.02K

% TURNOVER3,519.71%

TURNOVER--

P/E (TTM)-0.3887

% RANGE285.06%

EPS(TTM)-22.9720

P/E(FORWARD)-0.0193

P/B7.48

BVPS1.193

DIVIDEND--

P/S--

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP4.89M

SHARES OUTSTANDING547.77K

NEXT EARNINGS11/10-11/16

FREE FLOAT547.42K

LOT SIZE1

EX-DATE08/31/2026

News

Press Releases

Financial Reports

Profile

TipRanks·46m ago
Why Is Penny Stock Artelo Biosciences (ARTL) Up Over 200% Today?
NASDAQ·3h ago
Artelo Expands ART27.13 Patent Coverage After Obesity Study Findings
TipRanks·6h ago
Artelo Biosciences files new provisional patent application covering ART27.13
NASDAQ·09/16 12:57
Artelo Reports ART27.13 Matches Semaglutide Weight Loss In Obesity Model
TipRanks·09/16 11:40
Artelo Biosciences announces results from nonclinical study of ART27.13
TipRanks·08/28 23:50
Artelo Biosciences Inc trading halted, news pending
Dow Jones·08/27 12:03
*Artelo Biosciences: Reverse Split Being Effected in Order to Increase Price Per Shr of Common Stk to Improve Marketability and Liquidity >ARTL
TipRanks·08/20 13:35
Artelo secures Japan patent allowance for ART27.13 commercial formulation
NASDAQ·08/18 07:14
Artelo Biosciences Receives U.S. Patent Notice Of Allowance For ART27.13; Stock Up
TipRanks·08/17 13:15
Artelo Biosciences receives notice of allowance from USPTO
Seeking Alpha·08/13 12:16
Artelo Biosciences GAAP EPS of -$0.89
Dow Jones·08/13 12:03
*Artelo Biosciences Cash and Investments Totaled $4.2M as of June 30 >ARTL
Dow Jones·08/13 12:02
*Artelo Biosciences 2Q Loss/Shr 89c >ARTL
Dow Jones·08/13 12:02
*Artelo Biosciences 2Q Loss $2.4M >ARTL
Dow Jones·08/13 12:00
Press Release: Artelo Biosciences Provides -2-

Same Industry

Name/Symbol

Change%

Price

ARTL

REGN

GridAI Tech

GRDX

+5.59%

3.590

BIONTECH

BNTX

+2.02%

98.00

United Therapeutics Corp.

UTHR

-0.31%

493.10

Vertex Pharmaceuticals Inc

VRTX

-1.55%

508.34

Siga Technologie

SIGA

+2.95%

3.140

Moderna

MRNA

+9.74%

169.04

Charles Riv Labs Intl Inc

CRL

-1.28%

278.06

MEDP

TLPH

ICON plc

ICLR

+3.31%

169.55

CBPO

Iqvia Hldgs Inc

IQV

+0.08%

270.09

MOLN

Arcturus Therape

ARCT

-5.32%

16.03

Gilead Sciences Inc

GILD

-0.52%

150.11

PRAH

Aptevo Therapeutics Inc

APVO

0.00%

1.840

Incyte Corp

INCY

-0.53%

124.65

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.